Consensus Simulations Plus, Inc.

Stocks

SLP

US8292141053

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 10:29:28 2026-06-22 EDT			5-day change	1st Jan Change
18.21 ^USD	-0.16%		+11.24%	-0.11%

06-18	Craig-Hallum Downgrades Simulations Plus to Hold From Buy, Adjusts Price Target to $18.50 From $31	MT
06-17	William Blair Downgrades Simulations Plus to Market Perform From Outperform	MT

Evolution of the Average Target: Simulations Plus, Inc.

Evolution of the Target Price: Simulations Plus, Inc.

Changes in Analyst Recommendations: Simulations Plus, Inc.

c2f.ooKhWEcFyeULmgb3Vf3s8CDOsKlytjvQzvigvkv36_c.2-nUExB95KR59VSEGNCFllfjytgc8Qq8jKDjxjuiu6_UzJEtLzG8o1LvcQ~ca1e729b7744224a92d277ce36af2f39

Analysts' recommendations: Simulations Plus, Inc.

06-18	Craig-Hallum Downgrades Simulations Plus to Hold From Buy, Adjusts Price Target to $18.50 From $31	MT
06-17	William Blair Downgrades Simulations Plus to Market Perform From Outperform	MT
12-18	BTIG Research Downgrades Simulations Plus to Neutral From Buy	MT
25-09-30	TD Cowen Initiates Simulations Plus at Hold With $16 Price Target	MT
25-07-15	KeyBanc Downgrades Simulations Plus to Sector Weight From Overweight, Removes $25 Price Target	MT
25-07-07	BTIG Adjusts Price Target on Simulations Plus to $25 From $41, Maintains Buy Rating	MT
25-01-08	KeyBanc Lowers Price Target on Simulations Plus to $35 From $40, Keeps Overweight Rating	MT
24-11-15	Stephens Initiates Simulations Plus at Overweight With $39 Price Target	MT
24-07-29	KeyBanc Initiates Simulations Plus at Overweight With $47 Price Target	MT
24-07-16	JMP Securities Initiates Simulations Plus at Market Perform	MT
24-07-03	Top Decliners	MT
24-06-28	William Blair Initiates Simulations Plus at Outperform	MT
24-06-13	Craig-Hallum Raises Price Target on Simulations Plus to $56 From $51, Maintains Buy Rating	MT
24-06-13	Oppenheimer Adjusts Price Target on Simulations Plus to $65 From $55, Maintains Outperform Rating	MT
23-10-26	Oppenheimer Adjusts Simulations Plus Price Target to $55 From $67, Maintains Outperform Rating	MT
23-06-21	Oppenheimer Raises Simulations' Plus Price Target to $67 From $65, Maintains Outperform Rating	MT
23-05-09	BTIG Initiates Simulations Plus at Buy With $55 Price Target	MT
22-12-22	Sidoti Cuts Price Target on Simulations Plus to $44 From $56, Keeps Neutral Rating	MT
22-10-27	Oppenheimer Adjusts Simulations Plus Price Target to $65 From $75, Maintains Outperform Rating	MT
22-08-29	Raymond James Adjusts Price Target on Simulations Plus to $70 From $54, Keeps Outperform Rating	MT
22-08-26	Raymond James Adjusts Simulations Plus Price Target to $70 From $54, Maintains Outperform Rating	MT
22-07-07	Craig Hallum Raises Simulations Plus' Price Target to $60 From $55, Buy Rating Kept	MT
21-10-26	Craig-Hallum Upgrades Simulations Plus to Buy From Hold; Price Target is $53	MT
21-07-13	SIMULATIONS PLUS : Oppenheimer Adjusts Simulations Plus PT to $75 From $85 Following Fiscal Q3 Miss, Maintains Outperform Rating	MT
21-07-13	SIMULATIONS PLUS : Craig-Hallum Adjusts Price Target on Simulations Plus to $65 From $74, Maintains Hold Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Objective/dr gap
SIMULATIONS PLUS, INC.		-5.43%
VEEVA SYSTEMS INC.		+60.13%
PRO MEDICUS LIMITED		+4.42%
SECTRA AB		+21.63%
HEARTFLOW, INC.		+9.99%
GENERATE BIOMEDICINES, INC.		+75.29%
OMNICELL, INC.		+56.94%
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-	+21.58%
B-SOFT CO.,LTD.		+74.13%
RAYSEARCH LABORATORIES AB	-	+58.65%
Average		+37.73%
Weighted average by Cap.		+39.19%